MP67 - MP67: Prostate Cancer: Localized: Surgical Therapy III

Poster Presenter(s)

• 

  Akinyemi Akintayo, MD

  Research Fellow
  Emory University

  PDF Poster Slides and Audio
• 

  Chandler Bronkema, BS

  Wayne State University School of Medicine

  PDF Poster Slides and Audio
• 

  Francesco Claps, MD

  Resident
  University of Trieste

  PDF Poster Slides and Audio
• RF

  Ryan Flannigan
• 

  Alexis Freedland, MS

  UC Irvine

  PDF Poster Slides
• 

  Jaime Herrera-Caceres

  Princess Margaret Cancer Centre, University of Toronto, University Health Network
• 

  Jim Hu, MD,MPH

  Weill Cornell Medicine

  PDF Poster Slides and Audio
• KK

  Kazumi Kamoi
• YK

  Younghwii Ko, MD

  Associate Professor
  Yeungnam University

  PDF Poster Slides and Audio
• RL

  Ryan Lee, BS

  Keck School of Medicine of USC

  PDF Poster Slides and Audio
• 

  Amy Luckenbaugh, MD

  Vanderbilt University Medical Center

  Poster
• 

  Julie Lynch, PhD, RN, MBA

  Research Scientist
  University of Massachusetts Boston

  PDF Poster Slides
• 

  Claudia Mercader, MD

  Clinic Hospital of Barcelona

  PDF Poster Slides and Audio
• 

  Nicholas Pickersgill, MD

  Washington University School of Medicine in St. Louis
• 

  Nithesh Ranasinha, MBChB

  University of Oxford

  PDF Poster Slides and Audio
• KR

  Kyle Rose, MD

  Mayo Clinic Arizona

  PDF Poster Slides and Audio
• 

  Werner Struss

  University Hospital Southampton

  PDF Poster Slides and Audio
• DV

  Damiano Vizziello
• AW

  Adrian Waisman Malaret, MD

  Beth Israel Deaconess Medical Center

  PDF Poster Slides and Audio
• SW

  Samuel Washington

Presentations:

• 7:00 AM – 9:00 AM

  MP67-01: Surgeon and patient factors impact total operative time of robot-assisted radical prostatectomy
  Ryan Lee, BS
• 7:00 AM – 9:00 AM

  MP67-02: A virtual prostate cancer clinic: patient triggered follow-up for definitively managed prostate cancer
  Werner Struss
• 7:00 AM – 9:00 AM

  MP67-03: Improvement in functional and oncological outcome in locally advanced prostate cancer by robot-assisted radical prostatectomy with 3D-cancer mapping guidance
  Kazumi Kamoi
• 7:00 AM – 9:00 AM

  MP67-04: Preoperative ¹⁸F-fluciclovine PET/CT findings may be predictive of post-operative prostate-specific antigen (PSA) in patients with high risk prostate cancer.
  Akinyemi Akintayo, MD – Emory University
• 7:00 AM – 9:00 AM

  MP67-05: Laroscopic radical prostatectomy using a real-time lymphangiography with transperineal injection of Indocyanine Green: results from a prospective study
  Francesco Claps, MD – Department of Urology, University of Trieste
• 7:00 AM – 9:00 AM

  MP67-06: Influence of node-positive disease after radical prostatectomy on biochemical recurrence and early oncologic outcomes in men with prostate cancer
  Samuel Washington
• 7:00 AM – 9:00 AM

  MP67-07: The survival benefit of RARP in comparison with RT manifested in elderly men ; A national wide observational study
  Younghwii Ko, MD – Yeungnam University Hospital
• 7:00 AM – 9:00 AM

  MP67-08: Salvage robot assisted radical prostatectomy vs salvage re-irradiation for patient with radio-recurrent prostate cancer after primary radiotherapy: oncological outcomes
  Damiano Vizziello
• 7:00 AM – 9:00 AM

  MP67-09: Racial Disparities in Continence after Radical Prostatectomy
  Jim C. Hu, MD,MPH – Weill Cornell Urology
• 7:00 AM – 9:00 AM

  MP67-10: A 17-gene genomic assay as a predictor of outcomes in African Americans with prostate cancer
  Julie A. Lynch, PhD, RN, MBA – VA Salt Lake City
• 7:00 AM – 9:00 AM

  MP67-11: Does Equal Access Mean Equal Treatment? Race and Treatment Received in an Equal Access Medical Center
  Alexis Freedland, MS
• 7:00 AM – 9:00 AM

  MP67-12: Anti-Androgens and Cabazitaxel in Defining Complete Response in Prostatectomy (ACDC Trial) (ACDC-RP)
  Jaime O. Herrera-Caceres
• 7:00 AM – 9:00 AM

  MP67-13: Comparison of morbidity between limited and extended pelvic lymph node dissection for prostate cancer: results from a large, clinically-integrated, randomized trial
  Claudia Mercader, MD – Clinic Hospital of Barcelona
• 7:00 AM – 9:00 AM

  MP67-14: Pre-operative Pelvic Floor Endurance Assessment May Allow Prediction Of Early Return To Continence After Radical Prostatectomy
  Adrian Jacobo Waisman Malaret, MD
• 7:00 AM – 9:00 AM

  MP67-15: Robot assisted radical prostatectomy with solid organ transplantation: surgical technique, complications, and oncologic outcomes
  Kyle M. Rose, MD
• 7:00 AM – 9:00 AM

  MP67-16: Getting advantage from the &[Prime]teachable moment&[Prime] at initial diagnosis of prostate cancer - Results of a randomized controlled physical exercise program
  Ryan Flannigan
• 7:00 AM – 9:00 AM

  MP67-17: Association between treatment for localized prostate cancer and mental health outcomes
  Amy N. Luckenbaugh, MD
• 7:00 AM – 9:00 AM

  MP67-18: Impact of treatment modality on overall survival in localized ductal prostate adenocarcinoma: A National Cancer Database analysis
  Chandler James Bronkema, BS
• 7:00 AM – 9:00 AM

  MP67-19: Ductal Adenocarcinoma of the Prostate: A systematic review and meta-analysis of incidence, presentation and management
  Nithesh Nithesh Ranasinha Ranasinha, MBChB – Oxford University
• 7:00 AM – 9:00 AM

  MP67-20: PREOPERATIVE PROSTATE MRI DOES NOT IMPACT SURGICAL OUTCOMES OF RADICAL PROSTATECTOMY
  Nicholas A. Pickersgill, MD